APO-LAMIVUDINE HBV
APO-LAMIVUDINE HBV
Approved
DIN Number
02393239
Drug Class
Human
Market Date
Sep 21, 2012
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02393239
AIG Number0128157003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AF05 LAMIVUDINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
LAMIVUDINEActive
Strength: 100 MG
Monograph: LAMIVUDINE